Molecular Quality Control Market – Global Industry Analysis and Forecasts (2024 – 2030)

Molecular Quality Control Market was valued at US$ 182.60 Bn. in 2023. The Global Molecular Quality Control Market size is estimated to grow at a CAGR of 6.5 % over the forecast period.
Molecular Quality Control Market Overview:
The report explores the Molecular Quality Control market’s segments (Product, Analyte Type, Application, and End-User). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2023. The report investigates the Molecular Quality Control market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Molecular Quality Control market’s contemporary competitive scenario.To know about the Research Methodology :- Request Free Sample Report
Molecular Quality Control Market Dynamics:
An increasing number of accredited clinical laboratories:

The number of laboratory tests being conducted has increased owing to the rising burden of various diseases worldwide. To meet this demand, the number of laboratories in the public as well as the private sector is cumulative. In most countries, clinical laboratories must secure an endorsement from regulatory bodies such as the International Organization for Standardization (ISO) 15189:2012 and other similar standards to perform diagnostic tests. During the accreditation process, the respective authorities evaluate the quality system and competence of a laboratory-based on laboratory-based. In 2023, the number of total laboratory entities registered for CLIA accreditation increased to 286,396 as compared to 259,967 in 2017. Also, in 2018, 15,353 laboratories received CLIA accreditation from several accreditation organizations.

Additional costs involved in quality control and high-cost constraints in hospitals and laboratories:

The setting up of a QC process in a clinical laboratory requires significant investments. Laboratories also need to maintain dedicated personnel to manage the QC system. Besides, QC procedures incur similar costs, regardless of the volume of tests performed. Hence, the cost of implementing QC procedures is very high for clinical laboratories working with low volumes of diagnostic tests. This, coupled with budgetary constraints in many hospitals and laboratories in developed and developing economies, is expected to result in the lower adoption of QC practices. These are some of the factors that are leading to limiting the growth of the market through the forecast period.

A Rise in the demand for multi-analyte control:

The technological advancements have led to the development of a new range of multi-analyte and multi-instrument controls. These advanced controls consolidate multiple instrument-specific controls into a single control, thereby enabling clinical laboratories to reduce costs. Also, these controls save the time involved in separate QC procedures for each invited some companies have also expanded their portfolio by adding new tests. For example, in February 2020, Bio-Rad Laboratories (US) launched EDX RP Positive Run Control, the first multi-analyte control to target 22 analytes in a single vial, which can save laboratories time and space on their instruments. Also, in 2020, Thermo Fisher Scientific (US) launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control to monitor and validate COVID-19 molecular diagnostic tests. The growing availability of such molecular quality controls for infectious diseases diagnostics and other applications is expected to support market growth through the forecast period.
Changing regulatory framework

Regulatory and legal requirements applied to IVD (including molecular diagnostics) in the US and European countries are becoming more stringent. In the US, IVD products are defined under 21 CFR 809 and regulated under guidelines like medical devices. The FDA released new FDA guidance documents. Under US federal regulations, device manufacturers must submit a 510 (k) application for any further modifications to a device. New applications may require software updates or new software installation in an existing device or any other changes made to these devices. There are an estimated 1, 00,000 laboratories in India, and because of low entry barriers, there is less reliance on molecular product quality with no quality assurance requirements mandate for molecular diagnostic testing procedures. Similarly, in Turkey, there is no accreditation system relevant to clinical laboratories, while in Argentina, laboratory accreditation is a voluntary process. However, laboratories are not opting for such accreditations as this may increase investment to meet the required standards of accreditation.
Molecular Quality Control Market Trends:
Molecular quality controls are used to detect genetic diseases as these aid in the interpretation of results. Downs Syndrome is a genetic disorder that causes because by abnormal cell division, which results in an extra full or partial copy of chromosome 21. As per the US Centers for Disease Control and Prevention (CDC), every year, around 6,000 newborns in the US suffer from Down syndrome. As a result, prenatal testing for Down syndrome is increasing in the country. Most inherited cases of breast cancer are associated with mutations in two genes: BRCA1 (Breast Cancer gene one) and BRCA2 (Breast Cancer gene two). As per the American Cancer Society, around 5% to 10% of breast cancer cases are hereditary, as a result of mutated genes passed from parent to children. Growing awareness of breast cancer increases the adoption of genetic testing for hereditary breast cancer. Additional, as per CDC, sickle cell disease (SCD) is a common genetic blood disorder in the US that affects ~70,000 to 100,000 Americans. More, as per the WHO, 5% of the world population is the carrier of the genes for hemoglobin disorders, such as sickle-cell disease and thalassemia. Thus, the increasing prevalence of such genetic diseases propels the demand for molecular quality controls.
Molecular Quality Control Market Segment Analysis:
By product, the molecular quality control market is segmented into Independent Controls and Instrument Specific Controls. The Independent control segment accounted for the largest share of the molecular quality control market in 2023. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the molecular quality control products market.
Global Molecular Quality Control Market, by Type 2023 (%)
by Analyte type, the molecular quality controls market is segmented into single-analyte controls and multi-analyte controls. Single-analyte controls segment accounted for the largest share of the molecular quality control market in 2023. This is because of the significant use of single plex assays in hospitals and the advantages associated with the use of single-analyte controls, such as simple analysis & interpretation and low risk of cross-reactivity.
Molecular Quality Control Market Regional Insights:
The North American region emerged as the dominant regional market share accounting for xx% and growing at a CAGR of 7.6% over the forecast period. North America was the largest regional market for molecular quality controls because of the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers in the region, and the easy accessibility to technologically advanced products in the region.

Asia Pacific region is expected to be the second dominant region in this market. This is because the presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular quality controls market.

The objective of the report is to present a comprehensive analysis of the global Molecular Quality Control Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear, futuristic view of the industry to the decision-makers.

The reports also help in understanding the Molecular Quality Control Market dynamic and structure by analyzing the market segments and projecting the Molecular Quality Control Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Molecular Quality Control Market make the report investor’s guide.
Molecular Quality Control Market Scope: Inquire before buying



Global Molecular Quality Control Market


Report Coverage
Details


Base Year:
2023
Forecast Period:
2024-2030


Historical Data:
2018 to 2023
Market Size in 2023:
US $ 182.60 Bn.


Forecast Period 2024 to 2030 CAGR:
6.5%
Market Size in 2030:
US $ 283.76 Bn.


 Segments Covered:
by Product
Independent Controls
Instrument-specific Controls


by Analyte type
Single-analyte Controls
Multi-analyte Controls


by Application
Infectious Diseases Diagnostics
Oncology Testing
Genetic Testing
Other Applications


by End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & CROs
Academic and Research Institutes
Other End Users



Molecular Quality Control Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Molecular Quality Control Market, Key Players are
1. Thermo Fisher Scientific Inc.
2. Bio-Rad Laboratories, Inc.
3. Microbiologics, Inc.
4. ZeptoMetrix Corporation
5. F. Hoffmann-La Roche Ltd
6. Abbott Laboratories
7. Quidel Corporation
8. Qnostics
9. Maine Molecular Quality Controls, INC.
10. Danaher
11. Helena Biosciences Europe
12. SERO AS
13. Technopath Clinical Diagnostics
14. Randox Laboratories Ltd
15. Seracare Life Sciences

Frequently Asked Questions:

1] What segments are covered in the market report?
Ans. The segments covered in the market report are based on Product, Analyte Type, Application, and End-User.

2] Which region is expected to hold the highest share in the market?
Ans. The North American region is expected to hold the highest share in the market.

3] What is the market size of the market by 2030?
Ans. The market size of the market by 2030 is US$ 283.76 Bn.

4] What is the forecast period for the market?
Ans. The Forecast period for the market is 2024-2030.

5] What was the market size of the market in 2023?
Ans. The market size of the market in 2023 was US$ 182.60 Bn